BBTV

About Us

all episodes

George Poste on the Jan Buck Show

1. Molecular Diagnostics As The Next Major Conceptual Transition
2. Mapping the Human Genome, And The Innovator’s Dilemma In The Pharma Industry
3. Taking Out A Small Number of Pharmaceutical Manufacturing Plants Could Dislocate Medicine Supply For Large Numbers of the Global Population
4. The Biodesign Institute, A Radical Experiment To Extract The Low Intensity Signal That May Be Indicative Of Disease
5. A Look to the Future: Personalized Medicine, Consumer Driven Health, Synthetic Biology

Fred Frank on the Jan Buck Show

1. Portrait of Wall Street’s Pioneer Drug Analysts
2. The Future of the Industry, and the Lehman / Barclays Deal.
3. Blockbuster Drugs, and the 3 Eras of the Biotech Industry.

  • Series

    • The Stem Cell Review
  • Shows

    • Biotech in the Money
    • Wall Street On BBTV
    • Science Breakthrough
    • The Jan Buck Show
    • 60sec Pitches
    • Special Interview
    • Report on Location
  • About the Show


    Jan Buck Show explores the life sciences industry, with the people who have shaped it and who are shaping it today.

  • ABOUT BIOBUSINESS.TV
  • BioBusiness.TV is the first independent Internet TV Network for biotechnology professionals. We create and syndicate video-based industry focused shows and series that range from scientific breakthroughs, to equity analyst insights, as well as C-level executive and investor interviews on strategy, management, policy, marketing, science and more. We strive to enhance the quality and accessibility of industry video programming, and to deliver information biotechnology professionals can rely on to make sound and informed decisions.

  • PARTNERING WITH BIOBUSINESS.TV
  • If you’ve got great video programs and a growing audience, let BioBusiness.TV help you take it to the next level through our Partner Program. You can reach out to us through our ‘contact us’ page.

  • DISCLAIMER
  • Viewers should verify all claims and do their own due diligence before investing in any securities mentioned on BioBusiness.TV.